204 related articles for article (PubMed ID: 19406971)
1. Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis.
Davison SN; Jhangri GS; Jindal K; Pannu N
Clin J Am Soc Nephrol; 2009 Jun; 4(6):1044-50. PubMed ID: 19406971
[TBL] [Abstract][Full Text] [Related]
2. Sodium removal in peritoneal dialysis: the role of icodextrin and peritoneal dialysis modalities.
Fourtounas C; Hardalias A; Dousdampanis P; Papachristopoulos B; Savidaki E; Vlachojannis JG
Adv Perit Dial; 2008; 24():27-31. PubMed ID: 18985997
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sodium removal in peritoneal dialysis patients treated by continuous ambulatory and automated peritoneal dialysis.
Maharjan SRS; Davenport A
J Nephrol; 2019 Dec; 32(6):1011-1019. PubMed ID: 31502219
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
5. Sodium removal in patients undergoing CAPD and automated peritoneal dialysis.
Rodríguez-Carmona A; Fontán MP
Perit Dial Int; 2002; 22(6):705-13. PubMed ID: 12556073
[TBL] [Abstract][Full Text] [Related]
6. Icodextrin produces higher ultrafiltration in diabetic than in non-diabetic patients on continuous cyclic peritoneal dialysis.
Ahmad M; Jeloka T; Pliakogiannis T; Tapiawala S; Zhong H; Bargman JM; Oreopoulos D
Int Urol Nephrol; 2008; 40(1):219-23. PubMed ID: 17990071
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure, volume, and sodium control in an automated peritoneal dialysis population.
Boudville NC; Cordy P; Millman K; Fairbairn L; Sharma A; Lindsay R; Blake PG
Perit Dial Int; 2007; 27(5):537-43. PubMed ID: 17704444
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
[TBL] [Abstract][Full Text] [Related]
9. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin.
Posthuma N; ter Wee PM; Niessen H; Donker AJ; Verbrugh HA; Schalkwijk CG
Perit Dial Int; 2001; 21(1):43-51. PubMed ID: 11280495
[TBL] [Abstract][Full Text] [Related]
10. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
[TBL] [Abstract][Full Text] [Related]
11. Comparison of continuous cycling peritoneal dialysis with continuous ambulatory peritoneal dialysis in children.
Alliapoulos JC; Salusky IB; Hall T; Nelson P; Fine RN
J Pediatr; 1984 Nov; 105(5):721-5. PubMed ID: 6502301
[TBL] [Abstract][Full Text] [Related]
12. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
[TBL] [Abstract][Full Text] [Related]
13. Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as compared with icodextrin.
Selby NM; Fonseca S; Hulme L; Fluck RJ; Taal MW; McIntyre CW
Nephrol Dial Transplant; 2005 Sep; 20(9):1848-53. PubMed ID: 15972319
[TBL] [Abstract][Full Text] [Related]
14. [Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients].
Dai HL; Lin AW; Qian JQ; Fang W; Ni ZH; Cao LO; Lin XH; Wu QW
Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2843-7. PubMed ID: 21162796
[TBL] [Abstract][Full Text] [Related]
15. Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Dialysis.
Gokal R; Mistry CD; Peers EM
Perit Dial Int; 1995; 15(6):226-30. PubMed ID: 7578498
[TBL] [Abstract][Full Text] [Related]
16. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; van Dorp W; Peers EM; Verbrugh HA
Perit Dial Int; 1997; 17(6):602-7. PubMed ID: 9655161
[TBL] [Abstract][Full Text] [Related]
17. Continuous ambulatory and continuous cycling peritoneal dialysis in children. A report of the Southwest Pediatric Nephrology Study Group.
Kidney Int; 1985 Mar; 27(3):558-64. PubMed ID: 3999544
[TBL] [Abstract][Full Text] [Related]
18. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
Canbakan M; Sahin GM
Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
[TBL] [Abstract][Full Text] [Related]
19. Biochemical parameters, nutritional status and efficiency of dialysis in CAPD and CCPD patients.
Gao H; Lew SQ; Bosch JP
Am J Nephrol; 1999; 19(1):7-12. PubMed ID: 10085443
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens.
Wang MC; Tseng CC; Tsai WC; Huang JJ
Perit Dial Int; 2001; 21(1):36-42. PubMed ID: 11280494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
